• Sonuç bulunamadı

Safety and Efficacy of Zonisamide inRefractory Epilepsy Patients: ClinicalExperience from a Tertiary Center

N/A
N/A
Protected

Academic year: 2021

Share "Safety and Efficacy of Zonisamide inRefractory Epilepsy Patients: ClinicalExperience from a Tertiary Center"

Copied!
6
0
0

Yükleniyor.... (view fulltext now)

Tam metin

Referanslar

Benzer Belgeler

Conclusion– In light of the results of this study, patients diagnosed with FS should be followed-up more closely in terms of potential epilepsy development in case of a history

Objectives: The coronavirus disease 2019 (COVID-19) pandemic is an extraordinary experience around the world; however, its effect on phys- ical activity, anxiety, and seizure

While most of the patient’s relatives in the study performed in Yuksekova in 2010 declared that the reason for epilepsy was brain disorder, the percentage of those having no idea

Participants’ demographic and clinical characteristics Epilepsy syndromeEEGMRIEpilepsyAEDs before CLBCLB dose at SideEfficacy surgery last visit (mg)effects Patient 1Focal

Demographic characteristics, neurological examination findings, etiological risk factors, seizure type, and frequency, electroencephalography and neuroimaging findings,

BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non- Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity.. Alessandrino

Nine patients in total (22.5%) were evaluated as unrespon- sive to clobazam (less than 50% reductions in seizures, who showed no response, who manifested side effects and

Conclusion: If patients with epilepsy can be predicted early in the disease, which group of the patients will not respond well to medical treatment; unlike other patients,